Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2017 13F Holders as of 30 Jun 2017
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 3,900,811
- Total 13F value
- $20,278,960
- Share change
- +124,014
- SEC-reported price per share
- $5.19
- Number of holders
- 30
- Value change
- +$545,423
- Number of buys
- 19
- Number of sells
- 7
- Shares outstanding
- 28,495,649
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2017
Institutions
30
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2017
Previous quarter: Q1 2017
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
31 Mar 2017
13F
Lead comparable stake: 11%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 11%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
11%
Artal Group S.A.
0.53%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.51%
VANGUARD GROUP INC
0.34%
Manatuck Hill Partners, LLC
0.29%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
11%
|
$18,187,000
3,056,680 shares
|
— | 31 Mar 2017 |
| Artal Group S.A. |
13F
Company
|
0.53%
|
$893,000
150,000 shares
|
— | 31 Mar 2017 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.51%
|
$866,000
145,000 shares
|
— | 31 Mar 2017 |
| VANGUARD GROUP INC |
13F
Company
|
0.34%
|
$584,000
97,778 shares
|
— | 31 Mar 2017 |
| Manatuck Hill Partners, LLC |
13F
Company
|
0.29%
|
$500,000
83,958 shares
|
— | 31 Mar 2017 |
| BlackRock Finance, Inc. |
13F
Company
|
0.29%
|
$485,000
81,507 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
30
Shares
3,900,811
Rows available
30
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
25
Q2 2017 holders
30
Holder diff
5
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q2 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend